Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
4.000
-0.010 (-0.25%)
At close: Apr 28, 2026, 4:00 PM EDT
3.840
-0.160 (-4.00%)
After-hours: Apr 28, 2026, 6:30 PM EDT
Cellectis Market Cap
Cellectis has a market cap or net worth of $291.55 million as of April 28, 2026. Its market cap has increased by 228.70% in one year.
Market Cap
291.55M
Enterprise Value
172.19M
1-Year Change
228.70%
Ranking
Category
Stock Price
$4.00
Market Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $291.55M, a decrease of -78.31%. That is a compound annual growth rate of -12.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 290.10M | -17.14% |
| Dec 31, 2025 | 350.10M | 169.72% |
| Dec 31, 2024 | 129.80M | -24.18% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LENZ Therapeutics | 294.10M |
| Compugen | 293.12M |
| Minerva Neurosciences | 288.26M |
| Editas Medicine | 284.81M |
| NovaBridge Biosciences | 283.34M |
| Zentalis Pharmaceuticals | 282.31M |
| AC Immune | 281.73M |
| C4 Therapeutics | 281.03M |